High-Risk Localized and Locally Advanced Prostate Cancer
Around 20%-30% of nonmetastatic prostate cancer patients have high-risk localized disease. The best treatment for high-risk localized disease is still unclear, and the reliability of the definition of "high-risk" may need to be validated first. Although recent advances in radiotherapy for...
সংরক্ষণ করুন:
| অন্যান্য লেখক: | |
|---|---|
| বিন্যাস: | বৈদ্যুতিক গ্রন্থের অধ্যায় |
| ভাষা: | ইংরেজি |
| প্রকাশিত: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | DOAB: download the publication DOAB: description of the publication |
| ট্যাগগুলো: |
ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|
| সংক্ষিপ্ত: | Around 20%-30% of nonmetastatic prostate cancer patients have high-risk localized disease. The best treatment for high-risk localized disease is still unclear, and the reliability of the definition of "high-risk" may need to be validated first. Although recent advances in radiotherapy for prostate cancer have yielded excellent long-term results, even in high-risk localized disease, there are no studies directly comparing it with local treatment options, such as prostatectomy. To address current challenges in high-risk localized and locally advanced prostate cancer, 12 original and 3 review articles covering aspects from basic research to clinical trials are published in this Special Issue. |
|---|---|
| দৈহিক বর্ননা: | 1 electronic resource (244 p.) |
| আইসবিএন: | books978-3-0365-8169-9 9783036581682 9783036581699 |
| প্রবেশাধিকার: | Open Access |